B

이글벳

044960KOSDAQ기타 전문 도매업

55.5 / 100

Reference Date: 2026-07-24

Financial Score25.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but Revenue metrics are weak. Slightly up 4.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Eglvet is a company specializing in the manufacturing and import of animal pharmaceuticals, leveraging the growth of the livestock industry both domestically and internationally. Its key products include nutritional supplements, antibiotics, and vaccines, with active expansion into overseas markets such as Africa, the Middle East, and Southeast Asia. The company is also exploring research opportunities in the growing pet pharmaceutical market.

Number of Employees

110people

Average Salary

48.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
9.68Industry Average 12.755.0Point

In line with industry avg

PBR
0.74Industry Average 0.582.5Point

Higher than industry avg (caution)

ROE
7.85Industry Average 2.097.0Point

3.8x industry avg (excellent)

Debt Ratio
6.70Industry Average 7.874.0Point

In line with industry avg

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲0.7% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲13.6% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.5% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 3,020Won52-week high 4,50052-week low 2,765
1-month return4.0Point

1m +4.14% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0